• 2021.0416

    In February 2021, Chinese guidelines for diagnosis and treatment of diabetic kidney disease (Registration number: IPGRP-2021CN035) were published online by the Chinese Society of Nephrology in the Chinese Journal of Nephrology. The guideline is based on domestic and international expert consensus and integrates the clinical experience of Chinese nephrologists. This guideline contains the diagnosis of diabetic kidney disease (DKD), renal pathology biopsy, treatment and management, management of complications, and rational application of commonly used drugs. The expert group has referred to the international guideline format in the preparation process based on the principles of rigor, conciseness, and authority. The guidelines reflect new trends and perspectives in the treatment of DKD and are of great value in further strengthening the understanding of DKD, standardizing the treatment system, formulating reasonable treatment principles, guiding the precise use of drugs, delaying the progression of kidney disease. It will improve the life quality of patients and could be used by physicians for reference in clinical work.

  • 2021.0416

    The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help to improve the reporting quality of the systematic reviews. The first edition of the PRISMA statement has been published over 10 years. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline.

  • 2021.0331

    In January 2021,Runsheng Xie published an article in Pharmacological Research entitled The RIGHT Extension Statement for Traditional Chinese Medicine: Development, Recommendations, and Explanation. Nowadays, the number of traditional Chinese medicine (TCM) guidelines is constantly increasing, but its reporting quality remains unsatisfactory. The group hopes that the RIGHT-TCM may assist TCM guideline developers in reporting guidelines, support journal editors and peer reviewers when considering TCM guideline reports, and help health care practitioners understand and implement a TCM guideline.

Register MORE
  • 2021.0506
    Although the number of acupuncture papers is increasing year by year, the production, use, dissemination and evaluation of acupuncture evidence are still facing great challenges. There are some problems in acupuncture randomized controlled trials, such as false randomization, non use of blind method, lack of method reports and vague statistical analysis, which lead to low credibility of evidence. It is necessary to create an acupuncture evidence ecosystem, solve the waste of evidence resources, and realize the effective transformation of evidence, so as to better realize the public health right and reduce the waste of medical resources.
Registration process and operational mode of a CPG registry